Stage IVB Colorectal Cancer Recruiting Phase 2 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0068497 (Stage IVB Colorectal Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03800602Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal CancerTreatment